NOVOMEDIX
NovoMedix has developed novel orally available small molecules with wide therapeutic windows to treat fibrotic disorders. While these molecules have shown remarkable efficacy in animal models of fibrosis, some of them have unique properties for the treatment of cancer. These first-in-class small molecules co-target pathways that provide cardioprotective and synergistic anti-tumor effects with standard-of-care chemotherapies for the treatment of triple negative breast cancer (TNBC). There is a do... se-dependent delayed and progressive cardiomyopathy often observed years after cessation of treatment of breast cancer patients anthracyclines such as doxorubicin (Adriamycin). As a result, the leading cause of death in breast cancer survivors is cardiovascular disease, often caused by the same treatments that once saved their lives. NovoMedix compounds have synergistic effects with chemotherapies on cancer cells, potentially enhancing patient response while significantly minimizing cardiotoxicity, ultimately improving long-term survival by reducing mortality due to heart failure. The goal is to initiate IND enabling studies with the lead candidate and to deliver this novel and safe therapy to TNBC patients as soon as possible.
NOVOMEDIX
Industry:
Biotechnology
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.novomedix.com
Status:
Active
Contact:
+1 858-350-8826
Email Addresses:
[email protected]
Total Funding:
2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF LetsEncrypt Nginx Google Google Cloud Google Cloud Iowa Unsplash Google No Translate
Similar Organizations
Geneius
Geneius is a Biotechnology company.
Current Advisors List
Current Employees Featured
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - NovoMedix
Official Site Inspections
http://www.novomedix.com Semrush global rank: 3.38 M Semrush visits lastest month: 4.65 K
- Host name: 54.91.215.35.bc.googleusercontent.com
- IP address: 35.215.91.54
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "NovoMedix"
Novomedix | Transforming the Treatment of Cancer and Fibrosis
We are a biotechnology company developing novel small molecule multi-pathway modulators for the treatment of cancer, fibrosis, and inflammatory diseases. We have amassed a significant โฆSee details»
About Us - NovoMedix
Our Management, Board of Directors, and Scientific Advisory Board are comprised of world-class drug development experts with proven expertise in cancer and fibrosis. Our team shares a collective vision to improve the โฆSee details»
NovoMedix - Crunchbase Company Profile & Funding
NovoMedix is a Biotechnology Company. View contacts for NovoMedix to access new leads and connect with decision-makers. NovoMedix has developed novel orally available small โฆSee details»
NOVOMEDIX, INC. - VentureRadar
Website: http://www.novomedix.com/ Develops novel small molecule multi-pathway modulators for cancer, fibrosis, and inflammatory disease treatment, with a lead oral candidate, NMX1, โฆSee details»
NovoMedix - LinkedIn
NovoMedix | 194 followers on LinkedIn. We are a biotechnology company developing novel, multi-pathway modulators for cancer and fibrosis | NovoMedix is a biotechnology company based out of 7966...See details»
Novomedix, LLC Company Profile | San Diego, CA | Competitors ...
Find company research, competitor information, contact details & financial data for Novomedix, LLC of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
Our Approach - NovoMedix
Our lead program, NMX1, is a novel, patented, orally available small molecule with excellent safety and PK properties that inhibits mTOR, secretion of IL-11, and expression of CXCR4. This unique mechanism allows NMX1 to act on โฆSee details»
NovoMedix Company Profile 2024: Valuation, Funding & Investors โฆ
NovoMedix is headquartered in San Diego, CA. What is the size of NovoMedix? NovoMedix has 7 total employees. What industry is NovoMedix in? NovoMedixโs primary industry is โฆSee details»
NovoMedix, LLC - BIO Investor Forum | BIO
NovoMedix, LLC is a pre-clinical stage biopharmaceutical company that discovers and develops small molecule therapeutics that target key regulatory pathways in life-threatening diseases. โฆSee details»
NovoMedix - Org Chart, Teams, Culture & Jobs - The Org
View NovoMedix's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
NovoMedix - Overview, News & Similar companies | ZoomInfo.com
May 25, 2022ย ยท NovoMedix contact info: Phone number: (858) 350-8826 Website: www.novomedix.com What does NovoMedix do? NovoMedix discovers and develops โฆSee details»
NovoMedix Receives Research Grant from the National Institutes โฆ
SAN DIEGO, May 26, 2022 /PRNewswire/ -- NovoMedix, LLC ("NovoMedix"), a biotechnology company creating novel, safe, and effective drugs to treat unmet medical needs, today โฆSee details»
NovoMedix Receives Research Grant from the National Institutes โฆ
May 26, 2022ย ยท NovoMedix, LLC ("NovoMedix"), a biotechnology company creating novel, safe, and effective drugs to treat unmet medical needs, today announced that the National Heart, โฆSee details»
Two New Classes of Drugs to Target Chemotherapy Resistant and โฆ
Nov 18, 2011ย ยท NovoMedix has recently developed two new classes of drugs with nanomolar efficacy in cell models of high-risk B-ALL (drug resistant Nalm-6, SupB15 [Ikaros deletion], and โฆSee details»
NMX-2 - Drug Targets, Indications, Patents - Synapse - Patsnap
About NovoMedix NovoMedix is a biotechnology company developing novel small molecule multi-pathway modulators for the treatment of fibrosis and cancer. NMX2, a lead oral small molecule โฆSee details»
NovoMedix gets NIH grant to advance NMX1 in TNBC
The NIH has awarded NovoMedix a $2m Phase II SBIR grant to further the development of novel small molecules that protect patients with triple-negative breast cancer (TNBC) from the long โฆSee details»
Contact - NovoMedix
We would love to hear from you. Reach out in the form below, and we will get a conversation started.See details»
Two New Classes of Drugs to Target Chemotherapy
Nov 18, 2011ย ยท NovoMedix has recently developed two new classes of drugs with nanomolar efficacy in cell models of high-risk B-ALL (drug resistant Nalm-6, SupB15 [Ikaros deletion], and โฆSee details»
Novomedix
Novo Medix Pharmaceutical Pvt. Ltd. is one of the fastest pharmaceutical companies in BHARAT. Supported by Quality manufacturing facilities, we provide high-quality, affordable medicines, โฆSee details»
News and Publications - NovoMedix
NovoMedix, LLC ("NovoMedix"), a biotechnology company creating novel, safe, and effective drugs to treat unmet ... Novel Dual MTOR Inhibitor/AMPK Activator Mitigates Doxorubicin โฆSee details»